Bio tech company updates — 11/15/2026
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Riflex Science, a biotech company developing anti-aging RNA therapeutics, has secured 7 billion won in Series A funding, according to a report published November 14. The research results provide no other verified company news from the past 24 hours.
Key Findings

- Riflex Science has secured 7 billion won in Series A funding. The company is developing anti-aging RNA therapeutics.
Details
The November 14 report identifies Riflex Science as a biotech company founded by a Seoul National University professor and working on anti-aging RNA therapeutics. It reports the company raised 7 billion won in Series A funding.

This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.